250,000
Participants
Start Date
February 7, 2021
Primary Completion Date
December 31, 2021
Study Completion Date
January 1, 2022
Self-benefit
Participants will be reminded that the vaccine helps protect themselves from COVID.
Prosocial-benefit
Participants will be reminded that the vaccine helps protect their family, friends, and community from COVID
Early access
Participants will be reminded that they have early access to COVID-19 vaccine.
Fresh start
Participants will be reminded that the vaccine offers the promise of a fresh start and chart a new path forward.
UCLA Health Department of Medicine, Quality Office, Westwood, Los Angeles
Carnegie Mellon University
OTHER
University of California, Los Angeles
OTHER